Inventor · disambiguated record
Qiuqiong Tang
Also filed as: Tang Qiuqiong
7 granted patents·3 pending applications·6 citations·filing 2019–2025
74Inventor score
Files withASCENTAGE PHARMA SUZHOU CO LTD10
Top patents by PatentIndex Score
10 records- 0190US11452716B2Pharmaceutical composition and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Sep 27, 2022·3 cites·20 claims
- 0283US11478469B2Combination product of BCL-2 inhibitor and MDM2 inhibitor and use thereof in the prevention and/or treatment of diseasesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Oct 25, 2022·2 cites·10 claims
- 0378US12268665B2Combination of immunotherapies with MDM2 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Apr 8, 2025·1 cites·13 claims
- 0463US12370197B2Combination product of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent and use thereof in the prevention and/or treatment of diseasesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Jul 29, 2025·0 cites·8 claims
- 0563US12233047B2Pharmaceutical combination and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Feb 25, 2025·0 cites·20 claims
- 0657US2025235426A1Pharmaceutical Combination and Use ThereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2025·Application pending·0 cites
- 0752US12194024B2Pharmaceutical composition of MDM2 inhibitor and use thereof for preventing and/or treating diseaseASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Jan 14, 2025·0 cites·5 claims
- 0852US12186304B2Method for treating cancer by combination of IAP inhibitor and modulator of immune checkpoint moleculeASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Jan 7, 2025·0 cites·22 claims
- 0947US2021311020A1Treatment methods and biomarkers for mdm2 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Application pending·0 cites
- 1047US2025195473A1Combination of immunotherapies with mdm2 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qiuqiong Tang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →